Stem Cell Engineering and Automation Propel Allogeneic Cell Therapy Market Towards $1.97 Billion by 2026

GlobeNewswire (via Report Summary) USA

Overview

A new market study by Open PR forecasts a robust expansion for the allogeneic cell therapy market, projecting it to reach $1.97 billion by 2026. This significant growth is attributed to advancements in stem and immune cell engineering, increased investment in manufacturing infrastructure, and the rapid adoption of automated cell processing technologies. Innovations such as the Getinge and CellRev ‘Livit ACE’ platform for continuous adherent cell culture are key drivers shaping this market trajectory.

In Depth

Background

This report provides an overview of a recent market research study published by Open PR, which delves into the dynamics and future projections of the allogeneic cell therapy market. The study forecasts a substantial growth trajectory for this sector, anticipating a market valuation of $1.97 billion by 2026.

Key Findings

• The allogeneic cell therapy market is currently experiencing rapid growth, primarily fueled by groundbreaking advancements in both stem cell and immune cell engineering. This expansion is further supported by increasing financial investment into manufacturing infrastructure and the growing adoption of automated cell processing techniques.
• Technological innovation is a significant catalyst for market development. A notable example is the strategic partnership between Getinge and CellRev, which has led to the introduction of the ‘Livit ACE’ platform designed for continuous adherent cell culture, demonstrating a clear commitment to advancing the field.

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

• Your email and selected fields are used only to deliver the newsletter.
• We never share your information with third parties.
• You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Agree & Continue ▶

Takes about a minute · Unsubscribe anytime